How international medical insurance premiums are calculated

What the insurer is actually rating

Two people of the same age, holding the same plan with the same insurer and the same clean medical history, can be quoted materially different premiums because one lives in Kuala Lumpur and the other in Dubai. Nothing about them differs. What differs is the cost of the healthcare system they will use, how often people in that market claim, and where they would be sent if the local system could not treat them.

That is the shape of the whole calculation. An international medical insurance premium is not a price for you as an individual so much as a price for the risk cell you occupy — a combination of where you live, how old you are, what currency you pay in, and the shape of the cover you selected. Understanding which of those you can change is the difference between shopping the market usefully and simply collecting quotes.

The rating factors below are the ones providers publish themselves. Note the qualification that applies throughout: the fullest public account of pricing in this market is Bupa Global's guide to its pricing philosophy, a November 2024 document whose header states it is for broker and intermediary use only and is not intended as a consumer advertisement or to be relied on by consumers in making decisions about their insurance. It is quoted here as evidence of how an insurer describes its own method, not as advice you can act on.

The rating factors providers publish

The most itemised list comes from a policy document rather than a marketing page. William Russell's Personal Health plan agreement for the 2026 plan year sets out exactly what determines the premium for each new policy year: the member's age at the start of the year, the ages of eligible dependants, the number of eligible children insured, the plan, the coverage zone, the excess amount and the country of residence. It then adds a second category — general annual changes to premiums, and changes to the discounts and loadings applied to excesses, to child discounts, and to the discount for paying annually.

That two-part structure is the honest description of how renewal pricing works everywhere in this market. Part one is your own cell. Part two is what the insurer does to the whole book. A guide to why your premium increased deals with part two; the rest of this page deals with part one.

Country of residence, and the two questions behind it

Country of residence is the heaviest structural variable, and it is doing more work than "healthcare is expensive here". Bupa's account identifies two distinct enquiries. The first is how customers in that country actually behave — how readily they consult, how quickly they are referred, how much is done in-patient. The second is where they would go if treatment were not available locally, and what that destination costs. A member in a market with thin specialist provision carries the cost of the country they would be flown to, not only the country they live in.

This is why insurers insist on being told immediately when you move, and why several reserve the right to reprice or decline continued cover on relocation. William Russell's plan agreement goes further and states that where a member regularly takes treatment in a country that is not their declared country of residence, the insurer may use the country of treatment as the country of residence when calculating the renewal premium. Residence, for pricing purposes, is where the claims land.

The related lever you do control is the area of cover — the geography in which you are entitled to be treated, as distinct from where you live. The two interact, and narrowing the area is the single largest discretionary saving available in this market.

Age, gender and the limits of personal rating

Age is rated, and it is rated upwards. Bupa's pricing document describes the approach as simply increasing rates as customers get older, in line with risk, and quantifies the effect: on average, age increases can affect premiums by 3% to 8%. That figure is a book average from a November 2024 document, not a guarantee attaching to any individual policy, and it is separate from medical inflation.

Gender is not rated, at least within the European regulatory perimeter. Bupa's stated position is that EU regulation prevents pricing on gender, while age rating remains permitted. The consequence surprises people: because a bundled plan's maternity benefit cannot be charged only to women, it is funded by the whole pool. Members who will never use it are paying for it, which is a design decision made by regulation rather than by the insurer.

Lifestyle is generally not rated on an ongoing basis either. Health disclosures at application determine the terms you are offered — acceptance, an exclusion, or a loading — but improving your health mid-term does not produce a rebate, because the pricing is not built on your individual risk profile once cover is in force. The way medical history is handled at outset is a separate subject, covered in the guidance on switching insurer without losing continuity.

Currency, and why it is a rating factor at all

Insurers price in a small number of currencies — commonly US dollars, sterling and euros — and treat currency as a rating factor in its own right rather than a payment preference. Bupa lists premium payment currency alongside country, age and benefits. It explains the mechanism candidly: claims are accepted in many currencies and the insurer tries to absorb the exchange risk, but where a currency strengthens or weakens significantly, that can feed through into future premiums.

There is a second currency effect that sits on the claims side rather than the premium side. Where treatment is invoiced in a currency other than your policy currency, the insurer converts, and the order of operations matters — William Russell's wording converts the invoice into the policy currency, then deducts the excess and any co-insurance, then applies benefit limits, then converts again into the currency you asked to be paid in. Each step is a place where a moving rate changes what you actually receive.

The part you control: cover shape and cost sharing

Everything above is either fixed or determined by your life. What remains is the plan itself, and this is where most of the negotiable money sits.

• Area of cover. Whether the United States is in or out is the classic switch, but the more granular zone models go much further, down to regional-only cover. See what you give up on a worldwide-excluding-USA plan.
• Plan tier. In a bundled range, the tier sets both the annual maximum and the benefit rules, including the inner limits that constrain individual benefit lines; see tiers versus modules.
• Module selection. In a core-plus-modules range, out-patient cover, dental, maternity, wellness and even evacuation may be separately priced. What sits in the core and what does not varies sharply between providers — the subject of core cover versus optional modules.
• Cost sharing. Deductibles, per-claim excesses, co-insurance percentages and out-of-pocket maxima each shift risk back to you at a discount. The mechanics differ enough between insurers to matter, and are set out in deductibles, excess, co-insurance and out-of-pocket maximums.
• Family composition. Children are usually rated differently from adults, and some insurers apply child discounts or count the number of insured children as a discrete factor. See family and dependant cover.
• Payment frequency. Annual payment commonly attracts a discount; AXA Global Healthcare publishes a 5% saving for paying annually rather than in instalments.

The plan builder on this site walks through the same choices in the order an insurer's quotation engine asks them.

Risk pooling, and why there is no no-claims discount

The most common objection to international medical pricing is that a member who never claims funds one who claims constantly. That is precisely the design. Bupa states that it spreads claims risk across its entire customer base so that individual customers are not penalised when they need to make a claim, and it rejects a no-claims discount explicitly on the ground that such a discount may discourage people from seeking treatment.

Whatever you make of that as commercial positioning, it is internally consistent. A product whose purpose is to remove the financial hesitation before seeing a doctor cannot also price in a reward for not seeing one. It also explains a feature of the market that otherwise looks like an oversight: there is no equivalent of a motor no-claims bonus anywhere in mainstream international medical insurance, and a broker offering one should be asked what is actually being discounted.

What to check before comparing quotes

Comparison only works when the cells match. Before treating two quotations as comparable, confirm that they share a country of residence, an area of cover, a premium currency, a cost-sharing structure and an underwriting basis — a cheaper quotation written on a fresh medical lookback is not the same product as a dearer one carrying your existing terms across.

Then check the two pieces of the price that are not about you at all: the insurer's stated approach to annual rate changes, and whether the quotation is inclusive or exclusive of any insurance premium tax or local levy in your country of residence. Both routinely explain the gap between an illustration and an invoice. If the number you have been quoted is already at the edge of what you want to pay, read reducing an IPMI renewal premium before you buy rather than after, and the structural comparison in the existing provider comparison guide for how the four largest ranges differ in shape.